ÈäÅÍ ¸ð¾çÀ¸·Î ³ªÅ¸³­ ¸²ÇÁ°ü³» Á¶Á÷±¸Áõ½ÄÁõ
A Case of Scar-like Intralymphatic Histiocytosis

´ëÇÑÇǺΰúÇÐȸÁö 2014³â 52±Ç 7È£ p.490 ~ p.493

ÃÖÁøÈ­(Choi Jin-Hwa) - ¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
±èº´¼ö(Kim Byeong-Su) - ¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
¼Û½ÂÇö(Sohng Seung-Hyun) - ¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
½Åµ¿ÈÆ(Shin Dong-Hoon) - ¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
ÃÖÁ¾¼ö(Choi Jong-Soo) - ¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
¹è¿µ°æ(Bae Young-Kyung) - ¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract

Intralymphatic histiocytosis (ILH) is a rare, chronic cutaneous condition characterized by the presence of dilated lymphatic vessels containing aggregates of mononuclear histiocytes within lumina. ILH presents with asymptomatic and poorly demarcated, erythematous plaques or livedo reticularis-like lesions, usually located on the extremities. ILH is often associated with rheumatoid arthritis, metal joint implants, and mastectomy scars of breast cancer patients, but its pathogenesis remains uncertain. A 69-year-old woman with osteoarthritis, who had a past history of cancer in the left breast, presented with asymptomatic, linear-shaped, scar-like erythematous plaques on the right elbow for a month. Approximately a month before her visit, she had been treated with an intraarticular corticosteroid injection on the right elbow in a local clinic. Histopathologic findings showed irregularly dilated vessels with intraluminal cells in the superficial and deep dermis. In double immunohistochemical staining with CD68/D2-40, endothelial cells lining the vessels were positive for D2-40 staining, which is a marker for lymphatic endothelial cells, and intraluminal cells were positive for CD68 staining, which is a marker for histiocytes. We present the findings of a patient with a rare condition of intralymphatic histiocytosis with scar-like morphology of the plaques.

Å°¿öµå

Intralymphatic histiocytosis, Osteoarthritis, Scar
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå